Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody
-
Published:2023-12
Issue:
Volume:72
Page:103597
-
ISSN:0960-9776
-
Container-title:The Breast
-
language:en
-
Short-container-title:The Breast
Author:
Liu BinliangORCID,
Xie Ning,
Tian Can,
Feng Ronghua,
Hu Zhe-Yu,
Li Jing,
Liu Liping,
Xiao Huawu,
Yang Xiaohong,
Zeng Mengsi,
Wu Hui,
Lu Jun,
Gao Jianxiang,
Hu Xuming,
Cao Min,
Shui Zhengrong,
Tang Yu,
Wu Tao,
Ouyang Quchang
Subject
General Medicine,Surgery